Busulfan
Contents
Description
Busulfan is an alkylating agent used as a conditioning regimen prior to hematopoietic stem cell transplantation. It is commonly employed in the treatment of severe combined immunodeficiency disorders requiring bone marrow transplantation. The drug works by destroying bone marrow cells to prepare the patient for transplant.
Indications & Therapeutic Use
Conditioning treatment prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia, severe combined immunodeficiency
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Busulfan — GNH India
59 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Busulfan |
| Brands | 1 brand available |
| Active Ingredient | Busulfan |
| Drug Class | Conditioning treatment prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia |
| Manufacturer | Otsuka Pharmaceutical |
| Dosage Forms | IV infusion, 6mg/mL; Oral tablet, 2mg |
| Medical Code | L01AB01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00000000 |
| Countries | 5 countries |